Indication
Recurrent Clear Cell Renal Cell Carcinoma
1 clinical trial
1 product
1 drug
Clinical trial
A Phase II Study of Perioperative Pembrolizumab-Based Therapy in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma Prior to Cytoreductive Nephrectomy or MetastasectomyStatus: Recruiting, Estimated PCD: 2024-09-01
Product
AxitinibDrug
mFOLFOX6